ANKRD11 and diffuse large B-cell lymphoma: Interestingly, while the latter study found ANKRD11 mutations in 32% of EBV + HIV- DLBCL, none of the ANKRD11 mutations in our cohorts were found in EBV + tumors, indicating dysregulation of a more general immune mechanism, rather than an EBV-specific one37.